NMFS prohibits pot catcher/processor Pacific cod fishing BSAI

NMFS prohibits pot catcher/processor Pacific cod fishing BSAI

Extension of OMB Generic Clearance for Reviewer Recruitment Forms

ACF requests public comments on extending OMB clearance 0970-0477 for Reviewer Recruitment Forms. No substantive changes proposed to the generic clearance terms; burden estimates have been updated. The clearance covers forms used to recruit reviewers for grant proposals, research/evaluation plans, and other ACF materials. Comment period closes May 1, 2026.

Survey of State Government Research and Development Information Collection Extension

The Census Bureau submitted a request to OMB for a 3-year extension of the Survey of State Government Research and Development (SGRD), OMB Control No. 0607-0933. The survey collects R&D expenditure data from all 50 state governments, District of Columbia, and Puerto Rico on behalf of the National Science Foundation's National Center for Science and Engineering Statistics. The extension request includes no changes to the currently approved collection methodology.

Removal of Regulatory Overreach and Federal Crop Insurance Policy Provisions

FCIC issued a final rule removing provisions that improperly made final agency determinations binding on independent adjudicators such as Federal judges and the National Appeals Division. The rule aligns FCIC procedures with Supreme Court precedent from Perez v. Mortgage Bankers Ass'n and the Administrative Procedure Act. Additionally, FCIC will no longer codify detailed crop insurance policy provisions in the CFR, instead publishing policy terms through RMA official program materials.

NAL seeks OMB approval for user satisfaction survey

The National Agricultural Library (NAL) within USDA is seeking renewed OMB approval under the Paperwork Reduction Act to collect feedback on user satisfaction with NAL websites through short online surveys. The agency estimates 3,140 respondents annually with a total annual burden of 419 hours. Public comments on this information collection request must be submitted by June 30, 2026.

Updated OTC Derivatives Compliance Calendar

ISDA published its updated global OTC derivatives compliance calendar for April 2026, consolidating regulatory deadlines and compliance dates across multiple jurisdictions including the US, EU, UK, and Asia-Pacific. The calendar covers derivatives regulations under frameworks including EMIR, Dodd-Frank, Basel III, and MiFID II. No new regulatory requirements are created by this calendar update.

People v. Nielsen - Sentencing Appeal Affirmed

The California Court of Appeal affirmed Mark Nielsen's consolidated sentencing appeal across multiple criminal cases in Mendocino County. The court rejected Nielsen's arguments that the trial court improperly sentenced him to the upper term without applying the low term presumption under Penal Code § 1170(b)(6) and that custody credits were incorrectly calculated. Nielsen had been convicted of vehicle theft, driving offenses, and methamphetamine transportation across four separate cases.

People v. Newt - Large-Capacity Magazine Conviction Reversed

The California Court of Appeal, First Appellate District, reversed defendant Robert Antoine-Deshawn Newt's felony conviction for receiving a large-capacity magazine under Penal Code section 32310. The court found insufficient evidence to support felony 'receiving' rather than mere 'possession,' which is only a misdemeanor or infraction. The reversal restores the conviction to a misdemeanor level.

Contract Testing Laboratory CGMP Violations - Microbiological Testing & Consulting LLC

FDA issued Warning Letter 320-26-53 to Microbiological Testing & Consulting, LLC (FEI 3003875820) on March 16, 2026, citing significant CGMP violations found during a September 8-16, 2025 inspection of their contract testing laboratory in Alsip, IL. The agency identified failures in laboratory controls, inadequate documentation practices, and lack of appropriate media qualification for microbiological testing of drug products under 21 CFR parts 210 and 211.

Henan Lvyuan Pharmaceutical Co. Ltd. - CGMP Violations Warning Letter

The FDA Center for Veterinary Medicine issued Warning Letter 320-26-55 to Henan Lvyuan Pharmaceutical Co. Ltd., a Chinese manufacturer of active pharmaceutical ingredients (APIs) for veterinary and human drug compounding. The inspection from September 22-26, 2025 revealed significant CGMP violations including inadequate facility maintenance with extensive corrosion and water leaks that could contaminate APIs and compromise drug quality. The company must respond within 15 business days with corrective actions or face regulatory action including detention of products at U.S. borders.